Selpercatinib Increases Radioactive Iodine Avidity in RET-Fusion Pediatric Thyroid Carcinoma. Potter SL, Rainusso N, Sher AC, Quintanilla NM, et al. Pediatrics 2025 Nov 14:e2024070336. doi: 10.1542/peds.2024-070336.

Read + Share

Amedeo Smart

Independent Medical Education

Potter SL, Rainusso N, Sher AC, Quintanilla NM, et al. Selpercatinib Increases Radioactive Iodine Avidity in RET-Fusion Pediatric Thyroid Carcinoma. Pediatrics 2025 Nov 14:e2024070336. doi: 10.1542/peds.2024-070336.
PMID: 41232811